SBIR/STTR Research Award
OPTIMAL ISLET MATRIX FOR IMMUNOISOLATED TRANSPLANTS
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1991Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Cytotherapeutics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
THE LONG TERM OBJECTIVE OF THIS RESEARCH IS THE DEVELOPMENT AND INTRODUCTION INTO CLINICAL PRACTICE OF AN EFFECTIVE, AND BIOCOMPATIBLE IMPLANTABLE-HYBRID- ARTIFICIAL-PANCREAS WHICH IS CAPABLE OF SIGNIFICANT IMPROVEMENT IN THERAPY OF INSULIN DEPENDENT DIABETES. THE SPECIFIC AIM OF THIS PROJECT IS TO INVESTIGATE METHODS OF IMPROVING THE VIABILITY AND FUNCTION OF MACRO-ENCAPSULATED ISLETS. DEVELOPMENT OF THIS TECHNOLOGY MAY PERMIT THE EFFICACIOUS USE OF ANIMAL CELLS IN AN IMMUNOISOLATED ENVIRONMENT FOR THE EARLY TREATMENT OF INSULIN DEPENDENT DIABETES AND THUS IMPACT POSITIVELY ON THE PREVENTION OF THE DEBILITATING SECONDARY COMPLICATIONS ASSOCIATED WITH DISEASE.
Technology keywords
Not reported